# Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis

> **NCT02242474** · PHASE4 · UNKNOWN · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 660 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Anti-TNF suspended perioperatively
- **DRUG:** Anti-TNFα continued perioperatively

## Key facts

- **NCT ID:** NCT02242474
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 660 (ESTIMATED)
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242474, "Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02242474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*